This table presents recent patent oppositions filed by Chugai Seiyaku Kabushiki Kaisha against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP3365368Tgfbeta1-Binding Immunoglobulins And Use ThereofSCHOLAR ROCK, INC.Feb 16, 2024
EP2981822Compositions And Methods For Growth Factor ModulationSCHOLAR ROCK, INC.Jun 1, 2021
EP2956483Therapeutic And Diagnostic Target For Cancer Comprising Dll3 Binding ReagentsBOEHRINGER INGELHEIM INTERNATIONAL GMBHFeb 26, 2021

The following table provides an overview of the latest patents of Chugai Seiyaku Kabushiki Kaisha that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP3296395Jun 19, 2024Multiple Antigen Binding Molecular Fusion, Pharmaceutical Composition, Method For Identifying Linear Epitope, And Method For Preparing Multiple Antigen Binding Molecular Fusion1
EP3815688Dec 6, 2023Pharmaceutical Composition Containing Poorly-Soluble Basic Medicine2
EP2679681Nov 15, 2023Fc Riib-Specific Fc Antibody1
EP3320773Oct 11, 2023Non-Human Animal Having Human Cd3 Gene Substituted For Endogenous Cd3 Gene1
EP3199952Nov 2, 2022Method For Measuring Reactivity Of Fviii2
EP2578231Oct 26, 2022Antitumor T Cell Response Enhancer1
EP3330279Apr 6, 2022Method For Purifying Composition Comprising Antibodies With Anionic Polymer1
EP3130606Oct 13, 2021Immunoactivating Antigen-Binding Molecule2
EP3056568Sep 15, 2021Methods For Controlling Blood Pharmacokinetics Of Antibodies2
EP3342786Jun 23, 2021Anti-Dll3 Antibody2